#ITI#Antiviral efficacy of oseltamivir against avian influenza virus in avian species#FTI#
#IRE#Avian influenza is one of the most contagious viral diseases in bird species and, increasingly, interspecies transmission to mammalian species has been reported. Prevention and eradication of avian influenza virus (AIV) infection in birds may require vaccines as part of a comprehensive program including biosecurity, culling, diagnostics, and surveillance. However, for valuable bird species in zoos, novel eradication strategies are needed, including antiviral treatments. The present study evaluated the anti-influenza efficacy of the potent neuraminidase inhibitor oseltamivir in avian species using the orders Galliformes (chickens) and Anseriformes (ducks). Viral replication of low pathogenic AIV was significantly reduced in the chicken model and completely reduced in the duck model. Anti-influenza drug administration to valuable bird species with an appropriate extrapolation approach could be useful for control of AIV in combination with active surveillance and vaccination strategies. Further, evaluation of oseltamivir against highly pathogenic avian influenza (HPAI) using avian models would be needed to optimize the oseltamivir application guideline for HPAI control. Â© 2011 American Association of Avian Pathologists.#FRE#
#IPC#antiviral; avian influenza; chicken; duck; oseltamivir#FPC#
#IRF#Baigent S.J., McCauley J.W., Influenza type A in humans, mammals and birds: Determinants of virus virulence, host-range and interspecies transmission, BioEssays, 25, 7, pp. 657-671, (2003); 
Bertelsen M.F., Klausen J., Holm E., Grondahl C., Jorgensen P.H., Serological response to vaccination against avian influenza in zoo-birds using an inactivated H5N9 vaccine, Vaccine, 25, 22, pp. 4345-4349, (2007); 
Boltz D.A., Aldridge Jr. J.R., Webster R.G., Govorkova E.A., Drugs in development for influenza, Drugs, 70, pp. 1349-1362, (2010); 
Butt K.M., Smith G.J.D., Chen H., Zhang L.J., Leung Y.H.C., Xu K.M., Lim W., Webster R.G., Yuen K.Y., Peiris J.S.M., Guan Y., Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003, Journal of Clinical Microbiology, 43, 11, pp. 5760-5767, (2005); 
Furger M., Hoop R., Steinmetz H., Eulenberger U., Hatt J.-M., Humoral immune response to avian influenza vaccination over a six-month period in different species of captive wild birds, Avian Diseases, 52, 2, pp. 222-228, (2008); 
Hsu S.M., Chen T.H., Wang C.H., Efficacy of avian influenza vaccine in poultry: A meta-analysis, Avian Dis., 54, pp. 1197-1209, (2010); 
Hunter R.P., Isaza R., Concepts and issues with interspecies scaling in zoological pharmacology, J. Zoo Wildl. Med., 39, pp. 517-526, (2008); 
Kaleta E.F., Blanco Pena K.M., Yilmaz A., Redmann T., Hofheinz S., Aviares Influenza A-virus bei Vogeln der Ordnung Psittaciformes: Publikationen uber Virusisolierungen, Ubertragungsversuche und Vakzinationen Sowie Erste Studien zur Unschadlichkeit und Wirksamkeit von Oseltamivir in Ovo, Deutsche Tierarztliche Wochenschrift, 114, 7, pp. 260-267, (2007); 
Kapczynski D.R., Swayne D.E., Influenza vaccines for avian species, Curr. Top. Microbiol. Immunol., 333, pp. 133-152, (2009); 
Keawcharoen J., Oraveerakul K., Kuiken T., Fouchier R.A.M., Amonsin A., Payungporn S., Noppornpanth S., Wattanodorn S., Theamboonlers A., Tantilertcharoen R., Pattanarangsan R., Arya N., Ratanakorn P., Osterhaus A.D.M.E., Poovorawan Y., Avian influenza H5N1 in tigers and leopards, Emerging Infectious Diseases, 10, 12, pp. 2189-2191, (2004); 
Koch G., Steensels M., Van Den Berg T., Vaccination of birds other than chickens and turkeys against avian influenza, Rev. Sci. Technol., 28, pp. 307-318, (2009); 
Lecu A., De Langhe C., Petit T., Bernard F., Swam H., Serologic response and safety to vaccination against avian influenza using inactivated H5N2 vaccine in zoo birds, J. Zoo Wildl. Med., 40, pp. 731-743, (2009); 
Morens D.M., Taubenberger J.K., Historical thoughts on influenza viral ecosystems, or behold a pale horse, dead dogs, failing fowl, and sick swine, Influenza Other Respir. Virus., 4, pp. 327-337, (2010); 
Obon E., Bailey T.A., O'Donovan D., McKeown S., Kent J., Joseph S., Wernery U., Humoral response to H5N2 vaccination in exotic birds in the United Arab Emirates, Veterinary Record, 161, 25, pp. 860-861, (2007); 
Oh S., Martelli P., Hock O.S., Luz S., Furley C., Chiek E.J., Wee L.C., Keun N.M., Field study on the use of inactivated H5N2 vaccine in avian species [3], Veterinary Record, 157, 10, pp. 299-300, (2005); 
Olsen B., Munster V.J., Wallensten A., Waldenstrom J., Osterhaus A.D., Fouchier R.A., Global patterns of influenza a virus in wild birds, Science, 312, pp. 384-388, (2006); 
Philippa J., Baas C., Beyer W., Bestebroer T., Fouchier R., Smith D., Schaftenaar W., Osterhaus A., Vaccination against highly pathogenic avian influenza H5N1 virus in zoos using an adjuvanted inactivated H5N2 vaccine, Vaccine, 25, 19, pp. 3800-3808, (2007); 
Philippa J.D.W., Munster V.J., Bolhuis H.V., Bestebroer T.M., Schaftenaar W., Beyer W.E.P., Fouchier R.A.M., Kuiken T., Osterhaus A.D.M.E., Highly pathogenic avian influenza (H7N7): Vaccination of zoo birds and transmission to non-poultry species, Vaccine, 23, 50, pp. 5743-5750, (2005); 
Quirk M., Zoo tigers succumb to avian influenza, Lancet Infect. Dis., 4, (2004); 
Salomon R., Webster R.G., The influenza virus enigma, Cell, 136, pp. 402-410, (2009); 
Sambhara S., Poland G.A., H5N1 Avian influenza: Preventive and therapeutic strategies against a pandemic, Annu. Rev. Med., 61, pp. 187-198, (2010); 
Stirling J., Griffith M., Dooley J.S.G., Goldsmith C.E., Loughrey A., Lowery C.J., McClurg R., McCorry K., McDowell D., McMahon A., Millar B.C., Rao J., Rooney P.J., Snelling W.J., Matsuda M., Moore J.E., Zoonoses associated with petting farms and open zoos, Vector-Borne and Zoonotic Diseases, 8, 1, pp. 85-92, (2008); 
Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO, (2010)#FRF#
